BACKGROUND: Hematopoietic progenitors are generated in the yolk sac and aorta-gonad-mesonephros region during early mouse development. At embryonic day 10.5 the first hematopoietic stem cells emerge in the aorta-gonad-mesonephros. Subsequently, hematopoietic stem cells and progenitors are found in the fetal liver. The fetal liver is a potent hematopoietic site, playing an important role in the expansion and differentiation of hematopoietic progenitors and hematopoietic stem cells. However, little is known concerning the regulation of fetal liver hematopoietic stem cells. In particular, the role of cytokines such as interleukin-1 in the regulation of hematopoietic stem cells in the embryo has been largely unexplored. Recently, we observed that the adult pro-inflammatory cytokine interleukin-1 is involved in regulating aorta-gonad-mesonephros hematopoietic progenitor and hematopoietic stem cell activity. Therefore, we set out to investigate whether interleukin-1 also plays a role in regulating fetal liver progenitor cells and hematopoietic stem cells. DESIGN AND METHODS: We examined the interleukin-1 ligand and receptor expression pattern in the fetal liver. The effects of interleukin-1 on hematopoietic progenitor cells and hematopoietic stem cells were studied by FACS and transplantation analyses of fetal liver explants, and in vivo effects on hematopoietic stem cell and progenitors were studied in Il1r1(-/-) embryos. RESULTS: We show that fetal liver hematopoietic progenitor cells express the IL-1RI and that interleukin-1 increases fetal liver hematopoiesis, progenitor cell activity and promotes hematopoietic cell survival. Moreover, we show that in Il1r1(-/-) embryos, hematopoietic stem cell activity is impaired and myeloid progenitor activity is increased. CONCLUSIONS: The IL-1 ligand and receptor are expressed in the midgestation liver and act in the physiological regulation of fetal liver hematopoietic progenitor cells and hematopoietic stem cells.
BACKGROUND: Hematopoietic progenitors are generated in the yolk sac and aorta-gonad-mesonephros region during early mouse development. At embryonic day 10.5 the first hematopoietic stem cells emerge in the aorta-gonad-mesonephros. Subsequently, hematopoietic stem cells and progenitors are found in the fetal liver. The fetal liver is a potent hematopoietic site, playing an important role in the expansion and differentiation of hematopoietic progenitors and hematopoietic stem cells. However, little is known concerning the regulation of fetal liver hematopoietic stem cells. In particular, the role of cytokines such as interleukin-1 in the regulation of hematopoietic stem cells in the embryo has been largely unexplored. Recently, we observed that the adult pro-inflammatory cytokine interleukin-1 is involved in regulating aorta-gonad-mesonephros hematopoietic progenitor and hematopoietic stem cell activity. Therefore, we set out to investigate whether interleukin-1 also plays a role in regulating fetal liver progenitor cells and hematopoietic stem cells. DESIGN AND METHODS: We examined the interleukin-1 ligand and receptor expression pattern in the fetal liver. The effects of interleukin-1 on hematopoietic progenitor cells and hematopoietic stem cells were studied by FACS and transplantation analyses of fetal liver explants, and in vivo effects on hematopoietic stem cell and progenitors were studied in Il1r1(-/-) embryos. RESULTS: We show that fetal liver hematopoietic progenitor cells express the IL-1RI and that interleukin-1 increases fetal liver hematopoiesis, progenitor cell activity and promotes hematopoietic cell survival. Moreover, we show that in Il1r1(-/-) embryos, hematopoietic stem cell activity is impaired and myeloid progenitor activity is increased. CONCLUSIONS: The IL-1 ligand and receptor are expressed in the midgestation liver and act in the physiological regulation of fetal liver hematopoietic progenitor cells and hematopoietic stem cells.
Authors: D Rudolph; W C Yeh; A Wakeham; B Rudolph; D Nallainathan; J Potter; A J Elia; T W Mak Journal: Genes Dev Date: 2000-04-01 Impact factor: 11.361
Authors: David H McDermott; Ji-Liang Gao; Qian Liu; Marie Siwicki; Craig Martens; Paejonette Jacobs; Daniel Velez; Erin Yim; Christine R Bryke; Nancy Hsu; Zunyan Dai; Martha M Marquesen; Elina Stregevsky; Nana Kwatemaa; Narda Theobald; Debra A Long Priel; Stefania Pittaluga; Mark A Raffeld; Katherine R Calvo; Irina Maric; Ronan Desmond; Kevin L Holmes; Douglas B Kuhns; Karl Balabanian; Françoise Bachelerie; Stephen F Porcella; Harry L Malech; Philip M Murphy Journal: Cell Date: 2015-02-05 Impact factor: 41.582
Authors: Jenna M Frame; Caroline Kubaczka; Timothy L Long; Virginie Esain; Rebecca A Soto; Mariam Hachimi; Ran Jing; Arkadi Shwartz; Wolfram Goessling; George Q Daley; Trista E North Journal: Dev Cell Date: 2020-08-17 Impact factor: 12.270
Authors: Florian Leuschner; Philipp J Rauch; Takuya Ueno; Rostic Gorbatov; Brett Marinelli; Won Woo Lee; Partha Dutta; Ying Wei; Clinton Robbins; Yoshiko Iwamoto; Brena Sena; Aleksey Chudnovskiy; Peter Panizzi; Edmund Keliher; John M Higgins; Peter Libby; Michael A Moskowitz; Mikael J Pittet; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf Journal: J Exp Med Date: 2012-01-02 Impact factor: 14.307
Authors: Parham Solaimani Kartalaei; Tomoko Yamada-Inagawa; Chris S Vink; Emma de Pater; Reinier van der Linden; Jonathon Marks-Bluth; Anthon van der Sloot; Mirjam van den Hout; Tomomasa Yokomizo; M Lucila van Schaick-Solernó; Ruud Delwel; John E Pimanda; Wilfred F J van IJcken; Elaine Dzierzak Journal: J Exp Med Date: 2014-12-29 Impact factor: 14.307
Authors: Robert J Tower; Alec C Bancroft; Ashish R Chowdary; Spencer Barnes; Nicole J Edwards; Chase A Pagani; Lindsay A Dawson; Benjamin Levi Journal: Stem Cell Reports Date: 2022-09-22 Impact factor: 7.294
Authors: Bin Zhang; Su Chu; Puneet Agarwal; Victoria L Campbell; Lisa Hopcroft; Heather G Jørgensen; Allen Lin; Karl Gaal; Tessa L Holyoake; Ravi Bhatia Journal: Blood Date: 2016-09-12 Impact factor: 22.113
Authors: Somaiah Chinnapaka; Katherine S Yang; Yasamin Samadi; Michael W Epperly; Wen Hou; Joel S Greenberger; Asim Ejaz; J Peter Rubin Journal: Stem Cells Transl Med Date: 2021-03-16 Impact factor: 6.940